An E2F5-TFDP1-BRG1 Complex Mediates Transcriptional Activation of MYCN in Hepatocytes
Zhiwen Fan(Gezhouba Explosive (China)), Xiaolei Shi(Nanjing Drum Tower Hospital), Yan Guo(Zhongda Hospital Southeast University), Haozhen Ren(Nanjing Drum Tower Hospital), Hanyi Liu(Southwest University), Ning Tang(The Fourth People's Hospital of Ningxia Hui Autonomous Region), Shuai Wang(Zhengzhou University), Wei Zhu(Ministry of Education of the People's Republic of China), Jinglin Wang(Guizhou Provincial People's Hospital), Ming Kong(Soonchunhyang University Hospital Seoul), Zhengyi Zhu(Nanjing Drum Tower Hospital), Xiulian Miao(Liaocheng University), Longcheng Shang(China Pharmaceutical University)
Cited by 15
Related Papers
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
|Annals of the Rheumatic Diseases|2011|412
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
|PLoS ONE|2012|196
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
|Annals of the Rheumatic Diseases|2013|168